Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1996
10/02/1996DE19511322A1 Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung Sterile ophthalmic gels containing medium chain triglycerides and processes for their preparation
10/02/1996CN1132513A Process and antiparasitic intermediates for doramectin
10/02/1996CN1132512A C-22 ring stabilized rapamycin derivatives
10/02/1996CN1132511A Matrix metalloprotease inhibitors
10/02/1996CN1132510A Hydroisoquinoline derivatives
10/02/1996CN1132508A Piperazine derivatives
10/02/1996CN1132506A New Bis-naphthalimides for the treatment of cancer
10/02/1996CN1132505A Amidine derivatives with nitric oxide synthetase activities
10/02/1996CN1132504A Inhibitor of inhibiting generation of beta-amyloid
10/02/1996CN1132479A Mycophenolate mofetil high dose oral suspensions
10/02/1996CN1132478A A novel pharmaceutical for oral administration comprising progresterone and a polyethyelene glycol together with an exipient
10/02/1996CN1132475A Composion for releasing essence for nose
10/02/1996CN1132467A Substantive antimicrobial phosphates
10/02/1996CN1132209A New drug-polymeric mannuronic acid sulfate
10/02/1996CN1132206A Pyrrole derivatives
10/02/1996CN1132205A Novel pharmaceutical product
10/02/1996CN1132204A Novel heterocyclic amides
10/02/1996CN1132202A New benzopyran derivatives, their process of preparation and pharmaceutical compositions which contain them
10/02/1996CN1132201A Adhesion receptor antagonists
10/02/1996CN1132073A 1,3-oxathiolane nucleoside analogues
10/02/1996CN1132072A NK-1 receptor antagonists for treatment of neuronal injury and stroke
10/02/1996CN1132071A Medicinal compsn. for prevention and treatment of ischemic cerebral apoplexy
10/02/1996CN1132070A Aqueous suspension formulation for pharmaceutical applications
10/02/1996CN1032901C 5,10-methylentetrahydrofolic acid-cyclodextrin inclusion compounds
10/02/1996CN1032900C Method for prep. of locally-used metrohidazole formulations
10/01/1996US5561234 1-(7-chloroquinolin-4-yl)pyrazole-3-carboxamide N-oxide derivatives, method of preparing them, and their pharmaceutical compositions
10/01/1996US5561233 Process for the preparation of an intermediate of a benzo[a]quinolizinone derivative
10/01/1996US5561228 Immunosuppressnats; side effect reduction
10/01/1996US5561226 Process for the production of a pyrogen-free fructan which is readily water-soluble
10/01/1996US5561166 Urea/lactate topical compositions for dry skin
10/01/1996US5561165 Administering cholinergic agonist
10/01/1996US5561164 Administering 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone to an animal, including humans; also for kinetoplastida, apicomplexa, anaerobic infections
10/01/1996US5561163 Treating hearing loss with deprenyl
10/01/1996US5561161 Methods of administering and pharmaceutical formulations containing n-substituted benzamides and/or acid addition salts thereof
10/01/1996US5561160 Administering glucaric acid or salt thereof
10/01/1996US5561159 Topical applying to face
10/01/1996US5561158 Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging
10/01/1996US5561157 Method for enhancing the therapeutic effect of a composition comprising hydroquinone and comprising same
10/01/1996US5561156 Method of treating wrinkles using methyllactic acid
10/01/1996US5561155 Method of treating wrinkles using galacturonic acid or galacturonolactone
10/01/1996US5561154 Muscle relaxants
10/01/1996US5561153 Method of treating wrinkles using mucic acid or mucolactone
10/01/1996US5561152 1-phenoxy-2-(aminomethyl)indan derivatives; adrenergic blocking agent; inhibitors of both norepinephrine and serotonin uptake
10/01/1996US5561151 Antipyretic and analgesic methods of using optically pure R-etodolac
10/01/1996US5561150 Tricyclic pyrazole derivatives
10/01/1996US5561149 For nasal administration
10/01/1996US5561148 Oxazolidine derivative
10/01/1996US5561146 Modified guanidino and amidino thrombin inhibitors
10/01/1996US5561145 4-aryloxy- and 4-arylthiopiperidine derivatives
10/01/1996US5561144 (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
10/01/1996US5561141 MDR reversal agents
10/01/1996US5561140 Substituted alicyclic amine-containing macrocyclic immunomodulators
10/01/1996US5561138 Administering rapamycin by mouth, injection, nose, bronchi, skin or rectum; treating autoimmune hemolytic (warm or cold), transient drug induced, alloimmune or aplastic anemia
10/01/1996US5561136 Method of treating cancer by conjunctive therapy with N,N'-bis[ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent
10/01/1996US5561135 N,N,N',N'-tetrasubstituted-1,2-ethanediamine derivative compounds
10/01/1996US5561134 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
10/01/1996US5561133 Thymidylate synthase inhibiting quinazolinones
10/01/1996US5561132 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
10/01/1996US5561131 Increasing the wool growth by administering an antiprotozoa agent to sheep
10/01/1996US5561130 Azacyclic compounds
10/01/1996US5561129 Injecting intramuscularly sterile liquid formulation at specified ph and concentration
10/01/1996US5561128 N-[(4-(heteroaryl)-1-piperidinyl)alkyl]-10,11-dihydro-5H-dibenz[B,F]azepines and related compounds and their therapeutic utility
10/01/1996US5561126 4-oxa-1-azabicyclo [3,2,0] heptan-7-one derivatives as antitumor agents
10/01/1996US5561125 Antitumor agents
10/01/1996US5561124 Reducing prostate size; anticarcinogenin agents for adenocarcinoma; lowering levels of dihydrotestosterone; inconjuction with prescribed drugs in treating acne, seborrhea, hirsutism and alopecia
10/01/1996US5561123 Antitumor agents, anticarcinogenic agent
10/01/1996US5561121 Antitumor alkylating agent
10/01/1996US5561119 Glycosylated prodrugs, their method of preparation and their uses
10/01/1996US5561118 Antibiotics
10/01/1996US5561117 Bridged bis-aryl carbinol derivatives, compositions and methods of use
10/01/1996US5561112 Pseudopeptide isosteres of gly-asp and their use as antithrombic agents
10/01/1996US5561110 Administering oligopeptide
10/01/1996US5561060 Having pharmacological applicability
10/01/1996US5560935 Administering to inhibit plasma kallikrein production: improves peripheral blood flow, exhibits analgesic, antiinflammatory and antiallergic properties
10/01/1996US5560926 Rapid releasing; dry binder and compacted powder
10/01/1996US5560924 Antianalgesics, antiinflammatory and antipyratics; ketoprofen and s-naproxen
10/01/1996US5560922 17-beta-estradiol skin patches; drug delivery
10/01/1996US5560921 AMINOPHENYLALKANOL VASOCONSTRICTOR COMPLEXED WITH POLYMERIC POLYCARBOXYLATE; the amine group in pseudoephedrine, phenylephrine or a phenylpropanolamine interacts with acid group in methacrylic acid-methyl methacrylate copolymer (Eudragit); dosage form for fast release
10/01/1996US5560920 Calcium propionate and propylene glycol in paste stabilized with citric acid or phosphoric acid
10/01/1996US5560916 Cosmetic composition containing vinegar as active anti-ageing agent, and its use in the treatment of dermatological ageing
10/01/1996US5560914 Immunopotentiator and method of manufacturing the same
10/01/1996US5560912 Administering organic extract of cinnamon plant: activematerials are cinnamaldehyde and methoxycinnamaldehyde
10/01/1996US5560904 Cosmetic and/or dermatological composition containing a glyceryl tri(.alpha.
10/01/1996CA2173046A1 Process for preparation of benzo¬b|thiophene glucuronides
10/01/1996CA2172913A1 N-acylpiperazine derivative, antibacterial drug, and anti-ulcer drug
10/01/1996CA2033499C Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
10/01/1996CA2004468C Sustained release, comfort formulation for glaucoma therapy
10/01/1996CA1338627C Pharmaceuticals based on phosphoric acid esters for use in tumor therapy, and process for their preparation
10/01/1996CA1338625C Tricyclic compounds
09/1996
09/30/1996CA2171782A1 Antidepressant heteroarylaminoalkyl derivatives of naphthyl-monazines
09/28/1996CA2145605A1 Modulation of cellular activity
09/26/1996WO1996029604A1 Method for diagnosing a patient for chlamydia
09/26/1996WO1996029394A1 Method for treating tumors
09/26/1996WO1996029392A1 Methods for microbial regulation
09/26/1996WO1996029339A1 Fucopeptides
09/26/1996WO1996029337A1 Thiono triester modified antisense oligodeoxynucleotide phosphorothioates
09/26/1996WO1996029336A1 Chemical compounds
09/26/1996WO1996029333A1 Substituted tetronic acids useful for treating hiv and other retroviruses
09/26/1996WO1996029332A1 Process for isolating galanthamine
09/26/1996WO1996029328A1 Morpholine derivatives, compositions containing them and their use as therapeutic agents
1 ... 6875 6876 6877 6878 6879 6880 6881 6882 6883 6884 6885 6886 6887 6888 6889 6890 6891 6892 6893 6894 6895 ... 7860